Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies

被引：29

作者：

Sorrentino, Claudia ^{[1
]}

Cuneo, Antonio ^{[1
,2
]}

Roti, Giovanni ^{[1
]}

机构：

[1] Univ Parma, Dept Med & Surg, I-43126 Parma, Italy

[2] Univ Ferrara, Dept Med Sci, I-44121 Ferrara, Italy

来源：

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | 2019年 / 11卷

关键词：

NOTCH1; Targeted therapy; T-cell acute lymphoblastic leukemia; Chronic lymphocytic leukemia; Mantle cell lymphoma; PROTEASOME INHIBITOR BORTEZOMIB; GAMMA-SECRETASE INHIBITORS; MANTLE-CELL LYMPHOMA; ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL; B-CLL; ACTIVATING MUTATIONS; MONOCLONAL-ANTIBODY; TUMOR-GROWTH; APOPTOSIS;

D O I：

10.4084/MJHID.2019.037

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The Notch pathway plays a key role in several processes, including stem-cell self-renewal, proliferation, and cell differentiation. Several studies identified recurrent mutations in hematological malignancies making Notch one of the most desirable targets in leukemia and lymphoma. The Notch signaling mediates resistance to therapy and controls cancer stem cells supporting the development of on-target therapeutic strategies to improve patients' outcome. In this brief review, we outline the therapeutic potential of targeting Notch pathway in T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and mantle cell lymphoma.

引用

页数：13

共 119 条

[81] Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia [J].

Place, Andrew E. ;

Pikman, Yana ;

Stevenson, Kristen E. ;

Harris, Marian H. ;

Pauly, Melinda ;

Sulis, Maria-Luisa ;

Hijiya, Nobuko ;

Gore, Lia ;

Cooper, Todd M. ;

Loh, Mignon L. ;

Roti, Giovanni ;

Neuberg, Donna S. ;

Hunt, Sarah K. ;

Orloff-Parry, Sarah ;

Stegmaier, Kimberly ;

Sallan, Stephen E. ;

Silverman, Lewis B. .

PEDIATRIC BLOOD & CANCER, 2018, 65 (07)

[82] Molecular Pathways: Translational and Therapeutic Implications of the Notch Signaling Pathway in Cancer [J].

Previs, Rebecca A. ;

Coleman, Robert L. ;

Harris, Adrian L. ;

Sood, Anil K. .

CLINICAL CANCER RESEARCH, 2015, 21 (05) :955-961

[83] Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia [J].

Puente, Xose S. ;

Pinyol, Magda ;

Quesada, Victor ;

Conde, Laura ;

Ordonez, Gonzalo R. ;

Villamor, Neus ;

Escaramis, Georgia ;

Jares, Pedro ;

Bea, Silvia ;

Gonzalez-Diaz, Marcos ;

Bassaganyas, Laia ;

Baumann, Tycho ;

Juan, Manel ;

Lopez-Guerra, Monica ;

Colomer, Dolors ;

Tubio, Jose M. C. ;

Lopez, Cristina ;

Navarro, Alba ;

Tornador, Cristian ;

Aymerich, Marta ;

Rozman, Maria ;

Hernandez, Jesus M. ;

Puente, Diana A. ;

Freije, Jose M. P. ;

Velasco, Gloria ;

Gutierrez-Fernandez, Ana ;

Costa, Dolors ;

Carrio, Anna ;

Guijarro, Sara ;

Enjuanes, Anna ;

Hernandez, Lluis ;

Yaguee, Jordi ;

Nicolas, Pilar ;

Romeo-Casabona, Carlos M. ;

Himmelbauer, Heinz ;

Castillo, Ester ;

Dohm, Juliane C. ;

de Sanjose, Silvia ;

Piris, Miguel A. ;

de Alava, Enrique ;

Miguel, Jesus San ;

Royo, Romina ;

Gelpi, Josep L. ;

Torrents, David ;

Orozco, Modesto ;

Pisano, David G. ;

Valencia, Alfonso ;

Guigo, Roderic ;

Bayes, Monica ;

Heath, Simon .

NATURE, 2011, 475 (7354) :101-105

[84] Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth [J].

Qu, Fu-Lian ;

Xia, Bing ;

Li, Su-Xia ;

Tian, Chen ;

Yang, Hong-Liang ;

Li, Qian ;

Wang, Ya-Fei ;

Yu, Yong ;

Zhang, Yi-Zhuo .

CANCER BIOLOGY & MEDICINE, 2015, 12 (04) :401-408

[85] γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct [J].

Ran, Yong ;

Hossain, Fokhrul ;

Pannuti, Antonio ;

Lessard, Christian B. ;

Ladd, Gabriela Z. ;

Jung, Joo In ;

Minter, Lisa M. ;

Osborne, Barbara A. ;

Miele, Lucio ;

Golde, Todd E. .

EMBO MOLECULAR MEDICINE, 2017, 9 (07) :950-966

[86] NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia [J].

Real, P. J. ;

Ferrando, A. A. .

LEUKEMIA, 2009, 23 (08) :1374-1377

[87] γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia [J].

Real, Pedro J. ;

Tosello, Valeria ;

Palomero, Teresa ;

Castillo, Mireia ;

Hernando, Eva ;

de Stanchina, Elisa ;

Sulis, Maria Luisa ;

Barnes, Kelly ;

Sawai, Catherine ;

Homminga, Irene ;

Meijerink, Jules ;

Aifantis, Iannis ;

Basso, Giuseppe ;

Cordon-Cardo, Carlos ;

Ai, Walden ;

Ferrando, Adolfo .

NATURE MEDICINE, 2009, 15 (01) :50-58

[88] Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis [J].

Ridgway, John ;

Zhang, Gu ;

Wu, Yan ;

Stawicki, Scott ;

Liang, Wei-Ching ;

Chanthery, Yvan ;

Kowalski, Joe ;

Watts, Ryan J. ;

Callahan, Christopher ;

Kasman, Ian ;

Singh, Mallika ;

Chien, May ;

Tan, Christine ;

Hongo, Jo-Anne S. ;

de Sauvage, Fred ;

Plowman, Greg ;

Yan, Minhong .

NATURE, 2006, 444 (7122) :1083-1087

[89] Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia [J].

Rossi, Davide ;

Rasi, Silvia ;

Fabbri, Giulia ;

Spina, Valeria ;

Fangazio, Marco ;

Forconi, Francesco ;

Marasca, Roberto ;

Laurenti, Luca ;

Bruscaggin, Alessio ;

Cerri, Michaela ;

Monti, Sara ;

Cresta, Stefania ;

Fama, Rosella ;

De Paoli, Lorenzo ;

Bulian, Pietro ;

Gattei, Valter ;

Guarini, Anna ;

Deaglio, Silvia ;

Capello, Daniela ;

Rabadan, Raul ;

Pasqualucci, Laura ;

Dalla-Favera, Riccardo ;

Foa, Robin ;

Gaidano, Gianluca .

BLOOD, 2012, 119 (02) :521-529

[90] Genetic and proteomic approaches to identify cancer drug targets [J].

Roti, G. ;

Stegmaier, K. .

BRITISH JOURNAL OF CANCER, 2012, 106 (02) :254-261

← 3 4 5 6 7 8 9 10 11 12 →